- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02169076
Impact of Cardiac Resynchronization Therapy on Right Ventricular Function in Left Ventricular Assist Device Patients (CRT-LVAD)
Cardiac Resynchronization Therapy in Patients With Left Ventricular Assist Devices
Left Ventricular Assist Devices (LVAD) are mechanical heart pumps that are increasingly being implanted in patients with severe heart failure which have failed medical therapy. In patients with LVADs, right ventricular failure, which is not supported by the LVAD pump, is a major problem that affects quality-of-life and survival. Cardiac Resynchronization Therapy (CRT) aims to restore the synchronized contraction of the heart and has proven to be beneficial for improving ejection fraction of both right and left ventricle as well as quality of life in selected heart failure patients. The role of CRT in patients with LVADs is unknown. We hypothesize that CRT can exert a beneficial impact on right ventricular function in LVAD patients and improve their quality-of-life.
The specific questions that this study aims to answer are:
- What are the effects of CRT on the function of the non-supported right ventricle in patients with an implanted LVAD?
- Can the effects of CRT on cardiac function positively impact quality-of-life and exercise capacity in LVAD recipients?
In this study patients with a previously implanted CRT device, who later receives an LVAD, will be randomly assigned to have the CRT turned off (CRT-off) or on (CRT-on). The patients will be followed for an 8-week period, and then switched over to the opposite CRT status. The total participation in this study will last for 16 ± 1 weeks, and will involve 3 clinic visits of approximately 3 hour duration (initial visit, 8 week visit, and 16 week final visit), plus 2 quick checks of the pacemaker/defibrillator in-between the visits. Heart function will be assessed with comprehensive echocardiographic studies during the CRT "on" and CRT "off" periods. Quality-of-life and exercise capacity will be assessed with a standardized questionnaire and a 6-Minute Walk Test.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Kentucky
-
Louisville, Kentucky, United States, 40202
- Jewish Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Heart failure patients with previously implanted Bi-Ventricular pacemaker / defibrillator, and continuous flow LVAD (Heart Mate II® or HeartWare®)
- The LVAD must be implanted between 8 weeks and 18 months prior to enrollment
- Patients should be at least 3 weeks post discharge from the LVAD implant hospitalization
Exclusion Criteria:
Severe decompensated right ventricular failure defined as requiring any of the following:
- Hospitalization for heart failure within last 30 days
- Need for inotropic infusion for > 48h within the last 14 days
- Increase of > 100% diuretic dose within last 14 days
- Severe aortic regurgitation documented by echocardiography or cardiac catheterization
- Stage IV or greater kidney disease (GFR < 30 mL/min/1.73 m2)
- Active infection (not including controlled chronic driveline infection on suppressive antibiotic therapy)
- Biventricular pacing < 90 % of time due to uncontrolled arrhythmias
- LVAD malfunction
- Inability to follow study protocol
- Non-functional LV lead (i.e. high capture threshold that cannot be corrected with programming changes)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: CRT-On
Cardiac Resynchronization Therapy enabled on ICD/Pacemaker device
|
The cardiac resynchronization therapy of the ICD/Pacemaker device of the patients enrolled in the study will be programed under a standardized protocol and enabled or disabled in a crossover fashion during the study.
|
Sham Comparator: CRT-Off
Cardiac Resynchronization Therapy disabled on ICD/Pacemaker device
|
The cardiac resynchronization therapy of the ICD/Pacemaker device of the patients enrolled in the study will be programed under a standardized protocol and enabled or disabled in a crossover fashion during the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Right ventricular function
Time Frame: 8 weeks
|
The primary cardiac performance endpoint is global longitudinal right ventricular (RV) function assessed by myocardial strain analysis using Speckle Tracking Echocardiography (STE). Other traditional echocardiographic RV function indexes will also be evaluated. |
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Functional capacity
Time Frame: 8 weeks
|
Will be assessed by 6-Minute Walk Test
|
8 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality-of-Life
Time Frame: 8 weeks
|
Assessed by standardized self administered Minnesota Living with Heart Failure Questionnaire (MLHFQ)
|
8 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Rakesh Gopinathannair, MD, MA, FHRS, University of Louisville
- Principal Investigator: Martin A Espinosa Ginic, MD, University of Louisville
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14.0338
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
University Hospital, MontpellierCompletedHeart Failure | Diastolic Heart Failure | Systolic Heart Failure Stage CFrance
-
Lancaster General HospitalLouise von Hess Medical Research InstituteEnrolling by invitationDiastolic Heart FailureUnited States
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
-
US Department of Veterans AffairsCompleted
-
Giresun UniversityIstanbul University - Cerrahpasa (IUC)RecruitingHeart Failure | Diastolic Heart Failure | Systolic Heart FailureTurkey
Clinical Trials on Cardiac Resynchronization Therapy
-
Universitaire Ziekenhuizen KU LeuvenRecruitingHeart Failure | Cardiomyopathy, Dilated | Left Ventricular Dyssynchrony | Cardiac Remodeling, VentricularBelgium, Switzerland, Germany, France, Poland, Romania, Brazil, Hungary, Latvia, Portugal, Spain
-
Larisa TereshchenkoCompletedHeart Failure | Cardiomyopathy | Left Bundle Branch BlockUnited States
-
Paris Cardiovascular Research Center (Inserm U970)University Hospital, Montpellier; Groupe Hospitalier Pitie-Salpetriere; European... and other collaboratorsCompletedCongenital Heart Disease
-
Maastricht University Medical CenterMedtronicUnknownCardiac Resynchronization Therapy, Non-LBBB, QRS AreaNetherlands
-
Medtronic Latin AmericaUnknown
-
National University Heart Centre, SingaporeRecruitingHeart Failure | Cardiac Resynchronisation TherapySingapore
-
Maastricht University Medical CenterUniversity Medical Center Groningen; MedtronicCompletedHeart Failure | Left Bundle-Branch BlockNetherlands
-
Medtronic Cardiac Rhythm and Heart FailureCompletedHeart FailureUnited States